Healthcare -
Biotechnology - NASDAQ - US
$ 45.3
1.14 %
$ 2.62 B
Market Cap
-38.72
P/E
JANX - OPERATING INCOME
Operating Income JANX - Janux Therapeutics, Inc.
-73 M
LAST VALUE
-48.87%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR